Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6483]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014
mCRPC management in Taiwan - expert interview
Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014
The future of mCRPC treatment - expert discussion
Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and...
The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )
21 Mar 2014
ecancermedicalscience Editor's Choice for January 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014
MET variant as a prognostic marker in clear cell renal cell carcinoma
Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 Jan 2014
The role of molecular biology in the Identification of predictive factors for...
Dr José Antonio López - Instituto Valenciano de Oncología, Valencia, Spain
The role of molecular biology in the Identification of predictive factors for prostate cancer incidence ( Dr José Antonio López - Instituto Valenciano de Oncología, Valencia, Spain )
15 Jan 2014
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)
Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014
Predictors of response to mCRPC therapy: where do we stand?
Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center...
Predictors of response to mCRPC therapy: where do we stand? ( Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands )
10 Jan 2014
Translational studies of CDK and PARP inhibitors
Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013
HER2 positive breast cancer treatment, past and future
Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013
Careers in translational research
Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Careers in translational research ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013
Role of Bcl-2 family in lymphoid malignancies
Prof Andreas Strasser - University of Melbourne, Melbourne, Australia
Role of Bcl-2 family in lymphoid malignancies ( Prof Andreas Strasser - University of Melbourne, Melbourne, Australia )
18 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation